Exome Asset Management LLC Elevation Oncology, Inc. Transaction History

Exome Asset Management LLC

  • $165 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$0.23 - $0.39 $25,381 - $43,037
110,353 New
110,353 $40.5 Million
Q1 2024

May 15, 2024
BUY
$0.59 - $5.13 $217,899 - $1.89 Million
369,322 New
369,322 $1.89 Billion

Others Institutions Holding ELEV

# of Institutions
4
Shares Held
2.67M
Call Options Held
0
Put Options Held
0
View Full List

About Elevation Oncology, Inc.

ELEV Quotes by TradingView
  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $8.39M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email